| Capital Markets Industry | Financials Sector | - CEO | ASX Exchange | Q3464C116 CUSIP |
| United Kingdom Country | - Employees | - Last Dividend | 18 Nov 2020 Last Split | - IPO Date |
Seneca Growth Capital VCT plc is a venture capital trust that focuses on providing growth capital to emerging companies predominantly within the biotechnology sector. Its investment strategy is tailored towards supporting unquoted and quoted MedTech companies that exhibit significant growth potential. The trust maintains a geographical focus on investments within the United Kingdom, Île-de-France, Burgundy in France, and other European Developed Markets. Seneca Growth Capital VCT plc sets high standards for its investment portfolio, targeting companies that have already achieved sales greater than £10 million ($11.90 million), demonstrate a gross margin higher than 50%, and sustain an operating margin exceeding 10%. This disciplined approach ensures that the trust invests in businesses with robust financial health and strong growth prospects.
The key products and services offered by Seneca Growth Capital VCT plc encompass a range of investment solutions designed to support the growth and development of emerging biotechnology and MedTech companies. The trust specializes in: